Activities per year
Activities
- 26 results
Search results
-
The EGF receptor pathway in polycystic kidney disease
Gansevoort, R. (Supervisor)
2023Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Supervision of PhD student Abdulfataah Mohamed
Stevens, J. (Co-supervisor), Lambers Heerspink, H. (Supervisor), Gansevoort, R. (Supervisor) & van de Merbel, N. (Co-supervisor)
9-Jan-2022 → 9-Jan-2025Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
AGAINST Polycystic Liver Disease: estrogen as target for treatment
Gansevoort, R. (Supervisor)
2022Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Vasopressin V2 receptor antagonists in ADPKD. Improving aquaretic sideeffects and beyond
Gansevoort, R. (Supervisor)
2022Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Vasopressin and copeptin. Measurement, determinants and effects
Gansevoort, R. (Supervisor)
2022Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Predicting response to treatment in renal trials
Gansevoort, R. (Supervisor)
2022Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Pharmacokinetics and -dynamics of copeptin
Gansevoort, R. (Supervisor)
2020 → 2021Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
SGLT2 inhibition. Extending the use from diabetic to non-diabetic kidney disease
Gansevoort, R. (Supervisor)
2020Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Hepatic aspects of Polycystic Kidney Disease
Gansevoort, R. (Supervisor)
2020 → 2023Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
The EGF receptor pathway in ADPKD
Gansevoort, R. (Supervisor)
2020 → 2022Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
The SIMPLIFY project (SIMPLIFYing methods to accurately measure kidney function
Gansevoort, R. (Supervisor)
2020 → 2024Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Ameliorating polyuria during use of AVP V2 receptor antagonists
Gansevoort, R. (Supervisor)
2020 → 2021Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Palliative care in ADPKD
Gansevoort, R. (Supervisor)
2020 → 2022Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
CKD-PREDICT: Does Chronic Kidney Disease PREDispose to Incidence of Cancer Types?
Gansevoort, R. (Supervisor)
2020 → 2024Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
CKD. Insights from social and genetic epidemiology
Gansevoort, R. (Supervisor)
2020Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
A geriatric perspective on chronic kidney disease
Gansevoort, R. (Supervisor)
2019 → …Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
ADPKD, risk prediction for treatment selection
Gansevoort, R. (Supervisor)
2019Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Improving treatment and imaging in ADPKD
Gansevoort, R. (Supervisor)
2019Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Sodium and potassium intake as determinants of cardiovascular and renal health
Gansevoort, R. (Supervisor)
2019Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Prediction and monitoring of chronic kidney disease
Gansevoort, R. (Supervisor)
2017Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
ADPKD. Beyond growth and decline
Gansevoort, R. (Supervisor)
2017Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Hemodynamic stability during hemodialysis. A role for AVP?
Gansevoort, R. (Supervisor)
2016Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Vasopressin in chronic kidney disease, in particular ADPKD
Gansevoort, R. (Supervisor)
2016Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Albuminuria as pre-screening tool for better risk prediction
Gansevoort, R. (Supervisor)
2016Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Lanreotide for halting disease progression in ADPKD.
Gansevoort, R. (Supervisor)
2015Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Chronic kidney disease – the role of socio-economic status and implications for participation in social and work lives
Gansevoort, R. (Supervisor)
2015Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic